Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Nuo Therapeutics, Inc. (AURX)

  • SEC News
  • Oct. 30, 2025, 17:11 UTC
  • 4
  • 0 comments

New Form DEF 14A - Nuo Therapeutics, Inc. Filed: 2025-10-30 AccNo: 0001437749-25-032357 Size: 1 MB

Comment Full text

Precigen Inc (PGEN)

  • SEC News
  • Oct. 30, 2025, 16:50 UTC
  • 2
  • 0 comments

New Form SCHEDULE 13G/A - PRECIGEN, INC. Filed: 2025-10-30 AccNo: 0001085146-25-005965 Size: 8 KB

Comment Full text

PTC Therapeutics Inc (PTCT)

  • SEC News
  • Oct. 30, 2025, 16:24 UTC
  • 2
  • 1 comments

📋 Reeve Emma (Director) plans to sell 16K shares of PTC THERAPEUTICS, INC. (at $69.50 each, total $1.1M) Filed: Oct 30, 2025 | ID: 006610

Comment Full text

AtriCure Inc (ATRC)

  • SEC News
  • Oct. 30, 2025, 16:22 UTC
  • 2
  • 0 comments

New Form 10-Q - AtriCure, Inc. Filed: 2025-10-30 AccNo: 0001323885-25-000103 Size: 5 MB

Comment Full text

GSK plc (GLAXF)

  • SEC News
  • Oct. 30, 2025, 16:20 UTC
  • 1
  • 1 comments

(99% Neutral) PDMRperson, President (GSK plc) Reports Shares

Comment Full text

Bristol-Myers Squibb Company (BMY)

  • SEC News
  • Oct. 30, 2025, 16:05 UTC
  • 1
  • 0 comments

New Form 10-Q - BRISTOL MYERS SQUIBB CO Filed: 2025-10-30 AccNo: 0000014272-25-000149 Size: 13 MB

Comment Full text

89bio Inc (ETNB)

  • SEC News
  • Oct. 30, 2025, 16:05 UTC
  • 1
  • 0 comments

New Form 25-NSE - 89bio, Inc. Filed: 2025-10-30 AccNo: 0001354457-25-001073 Size: 3 KB

Comment Full text

Eli Lilly and Company (LLY)

  • SEC News
  • Oct. 30, 2025, 15:16 UTC
  • 1
  • 0 comments

New Form 10-Q - ELI LILLY & Co Filed: 2025-10-30 AccNo: 0000059478-25-000254 Size: 10 MB

Comment Full text

Medpace Holdings Inc (MEDP)

  • SEC News
  • Oct. 30, 2025, 14:38 UTC
  • 1
  • 1 comments

📋 DAVENPORT FRED B JR (Director) plans to sell 6K shares of Medpace Holdings, Inc. (at $581.88 each, total $3.5M) Filed: Oct 30, 2025 | ID: 006605

Comment Full text

Evaxion Biotech A/S (EVAX)

  • SEC News
  • Oct. 30, 2025, 13:30 UTC
  • 4
  • 1 comments

(99% Neutral) Evaxion Biotech A/S (EVAX) Files Form 6-K

Comment Full text
  • Previous
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next

Search

News categories

  • Technical Exchange News(10320)
  • Event(1442)
  • SEC News(175250)
  • FDA Approval(9644)
  • Company Report(721)
  • Business News(117525)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin